Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-23
DOI
10.1186/s12967-020-02522-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification and validation of immune-related lncRNA prognostic signature for breast cancer
- (2020) Yong Shen et al. GENOMICS
- Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer
- (2020) Muhammad Tarek Abdel Ghafar et al. MOLECULAR BIOLOGY REPORTS
- Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
- (2020) Le Zhang et al. Molecular Cancer
- Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study
- (2020) Muhammad Tarek Abdel Ghafar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21
- (2020) Zhuolu Wang et al. Frontiers in Endocrinology
- Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
- (2020) Bei Li et al. Frontiers in Oncology
- Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis
- (2020) Zhigang Yuan et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Immunotherapy in Anal Cancer
- (2020) Lisa Phuong et al. Current Oncology Reports
- Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway
- (2019) Gang Wang et al. Molecular Cancer
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma
- (2019) Yuting He et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
- (2019) Miki Takata et al. Frontiers in Immunology
- Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
- (2019) Na Li et al. EPMA Journal
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response
- (2019) Mahnaz Sahraei et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer
- (2019) Kehao Le et al. Scientific Reports
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- The regulation of lymphocyte activation and proliferation
- (2018) Susanne Heinzel et al. CURRENT OPINION IN IMMUNOLOGY
- Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study
- (2018) Abbas Shafiee et al. INTERNATIONAL JOURNAL OF CANCER
- ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
- (2018) Sanchita Bhattacharya et al. Scientific Data
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma
- (2018) Li Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profiles of long noncoding RNAs in lung adenocarcinoma
- (2018) Bing Zhao et al. OncoTargets and Therapy
- Research progresses in roles of LncRNA and its relationships with breast cancer
- (2018) Xu Bin et al. Cancer Cell International
- Long noncoding RNA s as regulators of cancer immunity
- (2018) Nerina Denaro et al. Molecular Oncology
- Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells
- (2018) Chulwoo Kim et al. Cell Reports
- Intergenic variants may predispose to major depression disorder through regulation of long non-coding RNA expression
- (2017) Ning Ye et al. GENE
- Cytokine-Mediated Regulation of Human Lymphocyte Development and Function: Insights from Primary Immunodeficiencies
- (2017) Stuart G. Tangye et al. JOURNAL OF IMMUNOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System
- (2017) Mariana Chavez‐MacGregor et al. ONCOLOGIST
- The functions of long noncoding RNAs in development and stem cells
- (2016) Rotem Ben-Tov Perry et al. DEVELOPMENT
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- From Discovery to Function: The Expanding Roles of Long NonCoding RNAs in Physiology and Disease
- (2015) Miao Sun et al. ENDOCRINE REVIEWS
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
- (2015) Wen Cheng et al. Oncotarget
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
- (2008) Wen-Jin Yin et al. BREAST CANCER RESEARCH AND TREATMENT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started